title: Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
abstract: The vitamin D receptor (VDR) binds to and mediates the effects of the 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) hormone to alter gene transcription. A newly recognized VDR ligand is the carcinogenic bile acid, lithocholic acid (LCA). We demonstrate that, in HT-29 colon cancer cells, both LCA and 1,25(OH)(2)D(3) induce expression of cytochrome P450 3A4 (CYP3A4), an enzyme involved in cellular detoxification. We also show that LCA-VDR stimulates transcription of gene reporter constructs containing DR3 and ER6 vitamin D responsive elements (VDREs) from the human CYP3A4 gene. Utilizing gel mobility shift, pulldown, and mammalian two-hybrid assays, we observe that: (i) 1,25(OH)(2)D(3) enhances retinoid X receptor (RXR) heterodimerization with VDR more effectively than LCA, (ii) the 1,25(OH)(2)D(3)-liganded VDR-RXR heterodimer recruits full-length SRC-1 coactivator, whereas this interaction is minimal with LCA unless LXXLL-containing fragments of SRC-1 are employed, and (iii) both 1,25(OH)(2)D(3) and LCA enhance the binding of VDR to DRIP205/mediator, but unlike 1,25(OH)(2)D(3)-VDR, LCA-VDR does not interact detectably with NCoA-62 or TRIP1/SUG1, suggesting a different pattern of LCA-VDR comodulator association. Finally, residues in the human VDR (hVDR) ligand binding domain (LBD) were altered to create mutants unresponsive to 1,25(OH)(2)D(3)- and/or LCA-stimulated transactivation, identifying S237 and S225/S278 as critical for 1,25(OH)(2)D(3) and LCA action, respectively. Therefore, these two VDR ligands contact distinct residues in the binding pocket, perhaps generating unique receptor conformations that determine the degree of RXR and comodulator binding. We propose that VDR is a bifunctional regulator, with the 1,25(OH)(2)D(3)-liganded conformation facilitating high affinity endocrine actions, and the LCA-liganded configuration mediating local, lower affinity cellular detoxification by upregulation of CYP3A4 in the colon.
authors.affiliation: Department of Biochemistry and Molecular Biophysics, University of Arizona College of Medicine, Tucson, AZ 85724, USA.
authors.forename: Peter W
authors.initials: PW
authors.lastname: Jurutka
authors.forename: Paul D
authors.initials: PD
authors.lastname: Thompson
authors.forename: G Kerr
authors.initials: GK
authors.lastname: Whitfield
authors.forename: Kristina R
authors.initials: KR
authors.lastname: Eichhorst
authors.forename: Neal
authors.initials: N
authors.lastname: Hall
authors.forename: Carlos Encinas
authors.initials: CE
authors.lastname: Dominguez
authors.forename: Jui-Cheng
authors.initials: JC
authors.lastname: Hsieh
authors.forename: Carol A
authors.initials: CA
authors.lastname: Haussler
authors.forename: Mark R
authors.initials: MR
authors.lastname: Haussler
mesh_terms: D001483:Base Sequence; D015153:Blotting, Western; D002117:Calcitriol / Q000494:pharmacology*; D002460:Cell Line; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000201:enzymology / Q000473:pathology; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D017931:DNA Primers; D006801:Humans; D008024:Ligands; D008095:Lithocholic Acid / Q000378:metabolism / Q000494:pharmacology*; D011401:Promoter Regions, Genetic; D018167:Receptors, Calcitriol / Q000378:metabolism*; D015533:Transcriptional Activation / Q000187:drug effects*
chemical_list: D017931:DNA Primers; D008024:Ligands; D018167:Receptors, Calcitriol; D008095:Lithocholic Acid; D003577:Cytochrome P-450 Enzyme System; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; D002117:Calcitriol